Brief: Immunovia Q4 Revenue SEK 455 Thousand

Immunovia AB (publ)

25/02/2025 07:30

Feb 25 (Reuters) - Immunovia Q4 adjusted free cash flow SEK -28.3 million.
* Q4 adjusted EPS SEK 0.02
* Q4 net income SEK 3.1 million